We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Emerging role of mesenchymal stromal cells in gynecologic cancer therapy.
- Authors
Song, Yizuo; Liu, Hejing; Pan, Shuya; Xiang, Xinli; Ye, Miaomiao; Zhu, Xueqiong
- Abstract
Mesenchymal stromal cells (MSCs) show considerable promise in regenerative medicine with superior anti-fibrotic, immunomodulatory, and angiogenic functions. More recently, discovered with the tumor tropism, MSCs have been exploited as the basis of targeted cancer therapy. In this scenario, MSCs can directly home to tumor tissues and play anti-tumor properties. In addition, MSCs, MSC-derived exosomes and MSC-derived membranes are often developed as carriers for precisely delivering cytotoxic agents to cancer sites, including chemotherapeutic drugs, therapeutic genes, or oncolytic viruses. However, it has revealed the tumorigenic risk of MSCs as an important component within the tumor microenvironment, hampering the translation of MSC-based cancer therapies into clinical settings. Therefore, in this review, we introduce the specific tumor-tropic ability of MSCs and underlying mechanisms. We also summarize the current application of MSC-based therapeutic approaches in treating gynecologic cancers, mainly including cervical, ovarian, and endometrial cancers. Moreover, we discuss the main challenges that the current MSC-based cancer therapies are facing.
- Subjects
STROMAL cells; CANCER treatment; GYNECOLOGIC cancer; CANCER cells; ENDOMETRIAL cancer; VIRAL tropism; REGENERATIVE medicine
- Publication
Stem Cell Research & Therapy, 2023, Vol 14, Issue 1, p1
- ISSN
1757-6512
- Publication type
Article
- DOI
10.1186/s13287-023-03585-0